Latest Breaking News On - தொலைநிலை மருந்து - Page 1 : comparemela.com

Anatara Lifesciences Limited (ASX:ANR) Chair Transition    Chair TransitionMelbourne, July 26, 2021 AEST (ABN Newswire) - Anatara Lifesciences ( ASX:ANR), a developer of evidence-based solutions for gastrointestinal diseases in humans and animals, is pleased to announce the transition of Dr David Brookes from Non-Executive Director to Chairman. Sue MacLeman will continue on the Board, transitioning from Chair to Non-Executive Director. The Board determined that, having successfully steered the Company following its decision to focus on the development of products and technologies in the human health sector with a focus on gut health, the time was now right for Dr Brookes to transition to the role of Chair as the Company progresses towards clinical trials.

Steven lydeamoreAnatara lifesciencesDavid brookesIsland pharmaceuticals ltdBetter medical groupAnatara lifesciences ltdAustralian college of ruralPerkinelmer incTali digital ltdNon executive directorSue maclemanNon executive chairmanFactor therapeuticsAustralian collegeRemote medicineAnatara chair